Roche Holding Company Profile (VTX:ROG)

About Roche Holding (VTX:ROG)

Roche Holding logoRoche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Diversified Electronics
  • Sub-Industry: N/A
  • Symbol: VTX:ROG
  • CUSIP: N/A
  • Web: www.roche.com
Average Prices:
  • 50 Day Moving Avg: CHF 127.48
  • 200 Day Moving Avg: CHF 111.47
P/E:
  • Trailing P/E Ratio: 33.39
  • P/E Growth: 1.63
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 21.17%
  • Return on Equity: 46.76%
  • Return on Assets: 14.96%
 

Frequently Asked Questions for Roche Holding (VTX:ROG)

What is Roche Holding's stock symbol?

Roche Holding trades on the VTX under the ticker symbol "ROG."

Where is Roche Holding's stock going? Where will Roche Holding's stock price be in 2017?

15 brokers have issued 12 month target prices for Roche Holding's stock. Their predictions range from CHF 210 to CHF 325. On average, they anticipate Roche Holding's stock price to reach CHF 265.07 in the next twelve months. View Analyst Ratings for Roche Holding.

Who are some of Roche Holding's key competitors?

Who are Roche Holding's key executives?

Roche Holding's management team includes the folowing people:

  • Severin Schwan, Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director
  • Alan Hippe, Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
  • Stephan Feldhaus, Member of the Enlarged Corporate Executive Committee, Head Group Communications
  • Sophie Kornowski-Bonnet, Member of the Enlarged Corporate Executive Committee, Head Roche Partnering
  • Osamu Nagayama, Member of the Enlarged Corporate Executive Committee, Chairman and Chief Executive Officer Chugai
  • John C. Reed M.D., Ph.D., Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
  • Michael David Varney, Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
  • Cristina A. Wilbur, Member of the Executive Committee, Head Group Human Resources
  • Urs Jaisli, Chief Compliance Officer
  • Gottlieb A. Keller, Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors


MarketBeat Community Rating for Roche Holding (VTX ROG)
Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  238 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  302
MarketBeat's community ratings are surveys of what our community members think about Roche Holding and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Roche Holding (VTX:ROG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 7 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.27)
Consensus Price Target: CHF 265.07
Consensus Price Target History for Roche Holding (VTX:ROG)
Price Target History for Roche Holding (VTX:ROG)
Analysts' Ratings History for Roche Holding (VTX:ROG)
Show:
DateFirmActionRatingPrice TargetDetails
10/18/2017Citigroup Inc.Set Price TargetNeutralCHF 255View Rating Details
10/18/2017Goldman Sachs Group, Inc. (The)Set Price TargetBuyCHF 325View Rating Details
10/16/2017J P Morgan Chase & CoReiterated RatingBuyView Rating Details
10/16/2017Jefferies Group LLCSet Price TargetBuyCHF 295View Rating Details
10/16/2017Credit Suisse GroupSet Price TargetNeutralCHF 260View Rating Details
10/6/2017Morgan StanleySet Price TargetNeutralCHF 260View Rating Details
10/4/2017Deutsche Bank AGSet Price TargetNeutralCHF 258View Rating Details
9/25/2017BNP ParibasSet Price TargetSellCHF 235View Rating Details
9/18/2017HSBC Holdings plcSet Price TargetSellCHF 210View Rating Details
9/13/2017Barclays PLCSet Price TargetBuyCHF 295View Rating Details
9/12/2017Baader BankSet Price TargetNeutralCHF 231View Rating Details
9/11/2017Kepler Capital MarketsSet Price TargetNeutralCHF 230View Rating Details
8/15/2017Berenberg BankSet Price TargetBuyCHF 273View Rating Details
7/27/2017Sanford C. BernsteinSet Price TargetBuyCHF 284View Rating Details
6/29/2017Societe GeneraleSet Price TargetNeutralCHF 275View Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for Roche Holding (VTX:ROG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Roche Holding (VTX:ROG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Roche Holding (VTX:ROG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roche Holding (VTX:ROG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Roche Holding (VTX:ROG)
Latest Headlines for Roche Holding (VTX:ROG)
Source:
DateHeadline
americanbankingnews.com logoJ P Morgan Chase & Co Reaffirms Buy Rating for Roche Holding Ltd. (ROG)
www.americanbankingnews.com - October 16 at 10:26 AM
americanbankingnews.com logoJefferies Group LLC Reiterates CHF 295 Price Target for Roche Holding Ltd. (ROG)
www.americanbankingnews.com - October 16 at 9:44 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 260 Price Target by Credit Suisse Group Analysts
www.americanbankingnews.com - October 16 at 7:20 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 325 Price Target by Goldman Sachs Group, Inc. (The) Analysts
www.americanbankingnews.com - October 15 at 1:30 PM
finance.yahoo.com logoStocks To Watch: Schulman A Sees Relative Strength Rating Jump To 83
finance.yahoo.com - October 12 at 9:02 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 260 Price Target by UBS AG Analysts
www.americanbankingnews.com - October 9 at 8:54 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 260 Price Target at Morgan Stanley
www.americanbankingnews.com - October 6 at 10:28 AM
americanbankingnews.com logoDeutsche Bank AG Reiterates CHF 258 Price Target for Roche Holding Ltd. (ROG)
www.americanbankingnews.com - October 4 at 6:38 AM
americanbankingnews.com logoBNP Paribas Analysts Give Roche Holding Ltd. (ROG) a CHF 235 Price Target
www.americanbankingnews.com - September 25 at 4:44 PM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Stock Rating Reaffirmed by J P Morgan Chase & Co
www.americanbankingnews.com - September 25 at 9:04 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 24 at 2:38 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) PT Set at CHF 290 by Jefferies Group LLC
www.americanbankingnews.com - September 22 at 12:02 AM
americanbankingnews.com logoBarclays PLC Analysts Give Roche Holding Ltd. (ROG) a CHF 295 Price Target
www.americanbankingnews.com - September 13 at 6:36 PM
marketwatch.com logoRoche: Zelboraf study failed to meet endpoint - MarketWatch
www.marketwatch.com - September 13 at 8:32 AM
americanbankingnews.com logoBaader Bank Analysts Give Roche Holding Ltd. (ROG) a CHF 231 Price Target
www.americanbankingnews.com - September 12 at 6:24 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 255 Price Target at Deutsche Bank AG
www.americanbankingnews.com - September 11 at 6:22 AM
americanbankingnews.com logoRoche Holding's (ROG) "Buy" Rating Reiterated at J P Morgan Chase & Co
www.americanbankingnews.com - September 11 at 6:20 AM
finance.yahoo.com logoRogers to Participate in Drexel Hamilton TMT Conference
finance.yahoo.com - September 6 at 7:47 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 30 at 2:34 AM
marketwatch.com logoRoche blood cancer drug gets FDA priority review - MarketWatch
www.marketwatch.com - August 29 at 7:20 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 335 Price Target at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - August 28 at 12:56 AM
marketwatch.com logoRoche hemophilia drug granted priority FDA review - MarketWatch
www.marketwatch.com - August 24 at 12:05 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Rogers Corp.
finance.yahoo.com - August 12 at 7:29 AM
nasdaq.com logoMexico watchdog finds big pharma faces no competition on some drugs - Nasdaq
www.nasdaq.com - August 10 at 7:30 AM
americanbankingnews.com logoRoche Holding Ltd. (VTX:ROG) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 5 at 2:34 AM
nasdaq.com logoRegeneron beats profit view, to end antibody deal with Sanofi - Nasdaq
www.nasdaq.com - August 4 at 7:41 AM
finance.yahoo.com logoRogers Corp. :ROG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 3, 2017
finance.yahoo.com - August 4 at 7:41 AM
finance.yahoo.com logoRogers Corporation Appoints Jeff Owens to Its Board of Directors
finance.yahoo.com - August 4 at 7:41 AM
nasdaq.com logoUS FDA panel votes against approval of J&J arthritis drug - Nasdaq
www.nasdaq.com - August 3 at 2:03 AM
finance.yahoo.com logoEdited Transcript of ROG earnings conference call or presentation 1-Aug-17 1:00pm GMT
finance.yahoo.com - August 2 at 7:18 AM
finance.yahoo.com logoRogers Corporation Reports Second Quarter 2017 Results
finance.yahoo.com - August 1 at 6:02 AM
finance.yahoo.com logoRogers Corp. posts 2Q profit
finance.yahoo.com - August 1 at 6:02 AM
thestreet.com logoCourt Ruling on 'Biosimilars' Sets Stage for More Drug Acquisitions - TheStreet.com
www.thestreet.com - July 29 at 6:52 AM
nasdaq.com logoRoche leukaemia drug gets FDA breakthrough therapy designation ... - Nasdaq
www.nasdaq.com - July 29 at 6:52 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Earns "Buy" Rating from J P Morgan Chase & Co
www.americanbankingnews.com - July 28 at 10:56 AM
americanbankingnews.com logoRoche Holding Ltd. (VTX:ROG) PT Set at CHF 260 by Deutsche Bank AG
www.americanbankingnews.com - July 28 at 10:25 AM
americanbankingnews.com logoRoche Holding Ltd. (VTX:ROG) PT Set at CHF 260 by UBS AG
www.americanbankingnews.com - July 27 at 8:27 AM
finance.yahoo.com logoRoche earnings beat expectations slightly
finance.yahoo.com - July 27 at 6:57 AM
finance.yahoo.com logoRoche CEO: Raising guidance after successful launch of ne...
finance.yahoo.com - July 27 at 6:57 AM
finance.yahoo.com logoOur strategy is to raise standard of care: Roche CEO
finance.yahoo.com - July 27 at 6:57 AM
finance.yahoo.com logoRoche CEO: Better-than-expected first-half earnings drive...
finance.yahoo.com - July 27 at 6:57 AM
finance.yahoo.com logoRogers Schedules Second Quarter 2017 Earnings Call for August 1
finance.yahoo.com - July 26 at 6:54 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) PT Set at CHF 335 by Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - July 23 at 1:19 PM
nasdaq.com logoChina adds blockbuster drugs to insurance list after price cuts - Nasdaq
www.nasdaq.com - July 19 at 7:25 AM
seekingalpha.com logoRoche's OCREVUS approved in Australia for the treatment of relapsing and primary progressive multiple sclerosis
seekingalpha.com - July 17 at 8:32 PM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 275 Price Target by Jefferies Group LLC Analysts
www.americanbankingnews.com - July 12 at 7:14 AM
americanbankingnews.com logoRoche Holding Ltd. (VTX:ROG) Given a CHF 215 Price Target at HSBC Holdings plc
www.americanbankingnews.com - July 11 at 12:42 PM
americanbankingnews.com logoRoche Holding's (VTX:ROG) Buy Rating Reiterated at J P Morgan Chase & Co
www.americanbankingnews.com - July 11 at 10:43 AM
americanbankingnews.com logoRoche Holding Ltd. (VTX:ROG) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - July 11 at 10:07 AM
americanbankingnews.com logoRoche Holding Ltd. (VTX:ROG) Rating Reiterated by Citigroup Inc.
www.americanbankingnews.com - July 9 at 9:40 PM

Social

Social activity is not available for this stock.
This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.